Advanced search
Start date
Betweenand

From metabolomics to treatment: novel approaches to understand heart failure

Grant number: 17/20593-7
Support Opportunities:Research Grants - Research Partnership for Technological Innovation - PITE
Duration: September 01, 2018 - August 31, 2022
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Convênio/Acordo: Agilent
Principal Investigator:Alexandre da Costa Pereira
Grantee:Alexandre da Costa Pereira
Host Institution: Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil
Host Company: Agilent Technologies Brasil Ltda
City: São PauloBarueri
Associated researchers: Cristine E. Seidman ; José Eduardo Krieger ; Karina Helena Morais Cardozo ; Valdemir Melechco Carvalho

Abstract

Heart failure (HF) is a national and global epidemic affecting millions of patients worldwide. HF is characterized by intense remodeling of the myocardium and important metabolic changes in cardiomyocyte biology. These changes are thought to be both a cause and consequence of the remodeling process and, thus, important targets for new pharmacological therapies. It is thus critically important that a detailed understanding of not only the main metabolic pathways altered in these disease states, but also the correlation structure of these changes with other impending systemic changes and embodied by transcriptional, epigenetic and functional remodeling of cardiomyocytes during the heart remodeling process is incorporated into our models of disease pathology. We propose to integrate metabolomics, functional, and molecular analyses of cell and animal model harboring genetic variants known to cause cardiomyopathies in humans and combine them with a unique set of animal and iPS-CM models to solve the pressing problem of characterizing metabolic pathways altered in these conditions and integrate these to derive mechanistic insights. This will lead to increased changes of translating this information into new, innovative, and specific therapeutic approaches to heart failure by different etiologies. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications (4)
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
CHU, SU H.; HUANG, MENGNA; KELLY, RACHEL S.; BENEDETTI, ELISA; SIDDIQUI, JALAL K.; ZELEZNIK, OANA A.; PEREIRA, ALEXANDRE; HERRINGTON, DAVID; WHEELOCK, CRAIG E.; KRUMSIEK, JAN; et al. Integration of Metabolomic and Other Omics Data in Population-Based Study Designs: An Epidemiological Perspective. METABOLITES, v. 9, n. 6, . (17/20593-7)
TITAN, SILVIA M.; VENTURINI, GABRIELA; PADILHA, KALLYANDRA; GOULART, ALESSANDRA C.; LOTUFO, PAULO A.; BENSENOR, ISABELA J.; KRIEGER, JOSE E.; THADHANI, RAVI I.; RHEE, EUGENE P.; PEREIRA, ALEXANDRE C.. Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: Results from the Progredir Cohort. PLoS One, v. 14, n. 3, . (11/17341-0, 15/23445-3, 17/20593-7)
OLIVEIRA, THEO G. M.; VENTURINI, GABRIELA; ALVIM, JULIANA M.; FEIJO, LARISSA L.; DINARDO, CARLA L.; SABINO, ESTER C.; SEIDMAN, JONATHAN G.; SEIDMAN, CHRISTINE E.; KRIEGER, JOSE E.; PEREIRA, ALEXANDRE C.. Different Transcriptomic Response to T. cruzi Infection in hiPSC-Derived Cardiomyocytes From Chagas Disease Patients With and Without Chronic Cardiomyopathy. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, v. 12, p. 12-pg., . (19/11821-1, 17/13706-0, 17/20593-7)
BAPTISTA, ALINE L.; PADILHA, KALLYANDRA; MALAGRINO, PAMELLA A.; VENTURINI, GABRIELA; ZERI, ANA C. M.; DOS REIS, LUCIENE M.; MARTINS, JANAINA S.; JORGETTI, VANDA; PEREIRA, ALEXANDRE C.; TITAN, SILVIA M.; et al. Potential Biomarkers of the Turnover, Mineralization, and Volume Classification: Results Using NMR Metabolomics in Hemodialysis Patients. JBMR PLUS, v. 4, n. 7, p. 9-pg., . (17/20593-7)

Please report errors in scientific publications list using this form.